Lanao, Estrella A.
HRN: 13-55-22 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/07/2026
CEFTRIAXONE 1G (VIAL)
04/07/2026
04/14/2026
IV
2G
OD
UTI
Checking Initial Appropriateness
04/08/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/08/2026
04/14/2026
IV
500mg
Q8
T/c Appendicitis
Checking Initial Appropriateness
04/11/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/11/2026
04/17/2026
IV
4.5g
Q8
Appendicitis
Checking Initial Appropriateness